Benjamin Paluch

Stock Analyst at Roth MKM

(0.35)

# 4,065

Out of 4,835 analysts

3

Total ratings

33.33%

Success rate

-16.05%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$25.43	+155.60%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$7.85	+116.56%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.48	+303.23%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $25.43

Upside: +155.60%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $7.85

Upside: +116.56%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.48

Upside: +303.23%